Elevated levels of mortalin expression in human brain tumors

Area of Science:

• Neuroscience
• Molecular Biology
• Oncology

Background:

• Mortalin (HSP70 family) exhibits differential intracellular distribution in normal versus transformed cells.
• Previous in vitro studies suggest mortalin's altered localization in cancer cells.

Purpose of the Study:

• To investigate mortalin expression patterns in normal human brain and various brain tumors.
• To determine the subcellular localization of mortalin in normal and malignant brain cells.
• To explore the correlation between mortalin expression and tumor grade/malignancy.

Main Methods:

• Immunohistochemistry on normal and tumor human brain sections.
• Immunofluorescence microscopy for subcellular localization studies in normal and glioblastoma cells.
• Correlation analysis with Ki-67 (cell proliferation marker).

Main Results:

• Mortalin expression is confined to neurons in normal brain tissue.
• Astrocytomas (low-grade to glioblastoma) and other brain tumors (meningiomas, pituitary adenomas, metastases) show increased mortalin-positive cells.
• Immunofluorescence suggests non-pancytosolic mortalin localization in glioblastoma cells.
• Increased mortalin-positive cells correlate with malignant progression and Ki-67 positivity.

Conclusions:

• Mortalin expression is upregulated in various human brain tumors compared to normal brain.
• The altered, non-pancytosolic localization of mortalin in tumors may be linked to malignant transformation.
• Mortalin's increased expression and altered localization suggest its potential involvement in brain tumor development and progression.